Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL973841 | 0.93 | — | — | |
| SCHEMBL973840 | 0.93 | — | — | |
| SCHEMBL5241244 | 0.93 | — | — | |
| Ethylene SCHEMBL27457191 | 0.91 | ALDH1A1 (0.35) | ALDH1A1 | |
| Acetic Acid SCHEMBL28594436 | 0.88 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL28098719 | 0.86 | ALDH1A1 (0.32) | ALDH1A1 | |
| Methacrylic Acid SCHEMBL28018917 | 0.83 | HSD17B10 (0.31) | ALDH1A1 | |
| Maleic Acid SCHEMBL20263088 | 0.81 | TSHR (0.36) | ALDH1A1 | |
| SCHEMBL4531306 | 0.77 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL4531307 | 0.77 | ALDH1A1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6605735-B2 | Ruthenium complex, process for producing the same and process for producing thin film | TOSOH CORPORATION (JP) | 2003-08-12 | — | — | US | disclosed |
| US-20030088116-A1 | RUTHENIUM COMPLEX, PROCESS FOR PRODUCING THE SAME AND PROCESS FOR PRODUCING THIN FILM | TOSOH CORPORATION | 2003-05-08 | — | — | US | disclosed |
| EP-1293509-A2 | Ruthenium complex, process for producing the same and process for producing thin film | Tosoh Corporation (JP) | 2003-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030088116-A1 | RUTHENIUM COMPLEX, PROCESS FOR PRODUCING THE SAME AND PROCESS FOR PRODUCING THIN FILM | EMG1, C5, VAMP7 | ALDH1A1 1075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.